N/A Completed N=60 Randomized Single-blind Supportive Care

Implementing and Evaluating the Genie Tool in COPD

Chronic Obstructive Pulmonary Disease · emphysema

Source: ClinicalTrials.gov NCT02935452 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Feb 2021

Primary outcomePrimary: Changes in EQ ED From Baseline to 3 Months Endpoint — 0.06; 0.04 score on a scale

Summary

The Generating Engagement in Network Involvement (GENIE) Tool is designed to support people to find and join social activities in their own neighbourhoods. Evidence has shown that people with more social support have increased ability to manage long term conditions and ill health. Patients with Chronic Obstructive Lung Disease (COPD) have difficulty breathing every day; this is both tiring and makes its difficult to socialise as they did prior to having their condition. COPD can be managed with medicines, and exercise, but will never be cured, so it is considered a 'long term condition.' This study plans to use a social mapping tool (GENIE) with COPD patients that are already part of the community service. The aim of the study is to increase opportunities to socialise and get day to day support outside of the health service. Patients will be offered either the tool, or usual care. If the study is successful then use of health care may reduce in the COPD patients already using the COPD service.

Outcome Measures

Outcome	Result	p-value
PRIMARY Changes in EQ ED From Baseline to 3 Months Endpoint	0.06; 0.04	—
PRIMARY Changes in the Symptom Burden of Disease From Baseline to 3 Months	-1.44; -0.14	—
PRIMARY Changes in Quality of Life (Mood) From Baseline to 3 Month Endpoint	-0.69; 0.4	—
PRIMARY Changes in Quality of Life (Anxiety) From Baseline to 3 Month Endpoint	-0.62; 0.76	—

Eligibility Criteria

Inclusion Criteria

Adults over 18 with a predominant diagnosis of COPD
Ability to understand spoken English
Attending PR assessment/ enrolled in Pulmonary Rehabilitation (PR) or maintenance therapy
Ability and capacity to make their own decision and consent freely

Exclusion Criteria

No clear COPD diagnosis
Inability to consent

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02935452). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.